[Form 4] CoreWeave, Inc. Insider Trading Activity
CoreWeave insider sale via 10b5-1 plan: Director Jack D. Cogen reported multiple sales of Class A common stock on 09/02/2025 executed under a Rule 10b5-1 trading plan adopted May 22, 2025. The Form 4 lists individual dispositions of 90,888; 160,174; 250,665; 473,236; 136,113; 928; and 261,140 shares at weighted-average prices ranging from $91.84 to $96.90 per share, resulting in large reductions in shares held indirectly through CW Holding 987 LLC. The filing discloses extensive remaining indirect holdings and trust/entity allocations, including a reported 1,200,000 shares held in the Cherry Tree 2024 GRAT and multiple family trust and LLC holdings. The Form 4 was signed by an attorney-in-fact on 09/04/2025.
Vendita interna CoreWeave tramite piano 10b5-1: Il direttore Jack D. Cogen ha comunicato più cessioni di azioni ordinarie di Classe A il 02/09/2025, eseguite nell'ambito di un piano di negoziazione Rule 10b5-1 adottato il 22/05/2025. Il Modulo 4 elenca singole disposizioni di 90.888; 160.174; 250.665; 473.236; 136.113; 928; e 261.140 azioni a prezzi medi ponderati compresi tra $91,84 e $96,90 per azione, con conseguenti significative riduzioni delle partecipazioni detenute indirettamente tramite CW Holding 987 LLC. La comunicazione indica ampie rimanenti partecipazioni indirette e assegnazioni a trust/entità, incluso un riportato possesso di 1.200.000 azioni nel Cherry Tree 2024 GRAT e molteplici detenzioni in trust familiari e LLC. Il Modulo 4 è stato firmato per delega da un procuratore il 04/09/2025.
Venta interna de CoreWeave mediante plan 10b5-1: El director Jack D. Cogen informó múltiples ventas de acciones ordinarias Clase A el 02/09/2025, ejecutadas bajo un plan de negociación Rule 10b5-1 adoptado el 22/05/2025. El Formulario 4 detalla disposiciones individuales de 90.888; 160.174; 250.665; 473.236; 136.113; 928; y 261.140 acciones a precios medios ponderados entre $91,84 y $96,90 por acción, resultando en importantes reducciones de las participaciones mantenidas indirectamente a través de CW Holding 987 LLC. La presentación revela amplias participaciones indirectas restantes y asignaciones a fideicomisos/entidades, incluyendo 1.200.000 acciones en el Cherry Tree 2024 GRAT y múltiples tenencias en fideicomisos familiares y LLC. El Formulario 4 fue firmado por un apoderado el 04/09/2025.
10b5-1 계획에 따른 CoreWeave 내부자 매도: 이사 잭 D. 코겐은 2025년 9월 2일에 여러 차례 클래스 A 보통주 매각을 보고했으며, 이는 2025년 5월 22일 채택된 Rule 10b5-1 거래 계획에 따라 실행되었습니다. Form 4에는 각각 90,888; 160,174; 250,665; 473,236; 136,113; 928; 및 261,140 주의 처분이 가중평균 주당 $91.84~$96.90 범위의 가격으로 기재되어 있으며, 이는 CW Holding 987 LLC를 통한 간접 보유 지분의 큰 감소를 초래했습니다. 해당 제출서는 남아 있는 광범위한 간접 보유 및 신탁/법인 배분을 공개하며, Cherry Tree 2024 GRAT에 보유된 1,200,000주 및 여러 가족 신탁과 LLC 보유를 포함합니다. Form 4는 2025년 9월 4일 대리인(법정대리인)에 의해 서명되었습니다.
Vente interne CoreWeave via plan 10b5-1 : L'administrateur Jack D. Cogen a déclaré plusieurs ventes d'actions ordinaires de Classe A le 02/09/2025, exécutées dans le cadre d'un plan de négociation Rule 10b5-1 adopté le 22/05/2025. Le formulaire 4 énumère des cessions individuelles de 90 888 ; 160 174 ; 250 665 ; 473 236 ; 136 113 ; 928 ; et 261 140 actions à des prix moyens pondérés allant de $91,84 à $96,90 par action, entraînant d'importantes réductions des actions détenues indirectement via CW Holding 987 LLC. Le dépôt divulgue d'importantes participations indirectes restantes et des allocations à des trusts/entités, y compris 1 200 000 actions détenues dans le Cherry Tree 2024 GRAT et de multiples avoirs en trusts familiaux et LLC. Le formulaire 4 a été signé par un mandataire le 04/09/2025.
CoreWeave Insider-Verkauf über 10b5-1-Plan: Direktor Jack D. Cogen meldete mehrere Verkäufe von Stammaktien Klasse A am 02.09.2025, ausgeführt im Rahmen eines Rule-10b5-1-Handelsplans, der am 22.05.2025 angenommen wurde. Das Formular 4 listet einzelne Veräußerungen von 90.888; 160.174; 250.665; 473.236; 136.113; 928; und 261.140 Aktien zu gewichteten Durchschnittspreisen zwischen $91,84 und $96,90 je Aktie auf, was zu erheblichen Reduzierungen der indirekt über CW Holding 987 LLC gehaltenen Anteile führte. Die Einreichung offenbart umfangreiche verbleibende indirekte Bestände und Zuweisungen an Trusts/Einheiten, darunter 1.200.000 Aktien im Cherry Tree 2024 GRAT sowie mehrere Familien-Trusts und LLC-Beteiligungen. Formular 4 wurde am 04.09.2025 von einem Bevollmächtigten unterschrieben.
- Sales executed under a documented Rule 10b5-1 trading plan, adopted May 22, 2025, indicating procedural compliance
- Filing discloses detailed weighted-average prices and multiple entity/trust holdings, supporting transparency in ownership reporting
- Large aggregate dispositions reported on 09/02/2025 (individual tranches of 90,888; 160,174; 250,665; 473,236; 136,113; 928; and 261,140 shares) reducing indirect holdings
- Significant ownership remains held indirectly across family trusts and LLCs but the sales materially change the composition of holdings managed by CW Holding 987 LLC
Insights
TL;DR: Significant insider sales executed under a 10b5-1 plan reduce indirect holdings materially and warrant monitoring of ownership changes.
Jack D. Cogen, a director and manager of CW Holding 987 LLC, reported multiple sales on 09/02/2025 under a Rule 10b5-1 plan. The reported dispositions list several tranches sold at weighted-average prices between $91.84 and $96.90. The transactions were effected through the entity he manages, and the filing disclaims beneficial ownership except to the extent of any pecuniary interest. The Form 4 also itemizes substantial retained indirect holdings across trusts and LLCs, including a 1,200,000-share position in the Cherry Tree 2024 GRAT. For investors, these are material ownership movements but the filing shows they were pre-planned under a compliance program, not ad-hoc trades.
TL;DR: Use of a documented 10b5-1 plan signals procedural compliance, though the scale of sales changes director-aligned ownership.
The Form 4 explicitly states the sales were made pursuant to a 10b5-1 trading plan adopted May 22, 2025, which provides an affirmative defense under Rule 10b5-1. The reporting person serves as manager of CW Holding 987 LLC and disclaims direct beneficial ownership beyond pecuniary interest, while numerous family trusts and LLCs hold additional shares. The filing includes precise weighted-average sale prices and multiple entity disclosures, demonstrating attention to compliance and detailed beneficial ownership reporting. Impact on governance is tied to the magnitude of reduced indirect holdings, as disclosed.
Vendita interna CoreWeave tramite piano 10b5-1: Il direttore Jack D. Cogen ha comunicato più cessioni di azioni ordinarie di Classe A il 02/09/2025, eseguite nell'ambito di un piano di negoziazione Rule 10b5-1 adottato il 22/05/2025. Il Modulo 4 elenca singole disposizioni di 90.888; 160.174; 250.665; 473.236; 136.113; 928; e 261.140 azioni a prezzi medi ponderati compresi tra $91,84 e $96,90 per azione, con conseguenti significative riduzioni delle partecipazioni detenute indirettamente tramite CW Holding 987 LLC. La comunicazione indica ampie rimanenti partecipazioni indirette e assegnazioni a trust/entità, incluso un riportato possesso di 1.200.000 azioni nel Cherry Tree 2024 GRAT e molteplici detenzioni in trust familiari e LLC. Il Modulo 4 è stato firmato per delega da un procuratore il 04/09/2025.
Venta interna de CoreWeave mediante plan 10b5-1: El director Jack D. Cogen informó múltiples ventas de acciones ordinarias Clase A el 02/09/2025, ejecutadas bajo un plan de negociación Rule 10b5-1 adoptado el 22/05/2025. El Formulario 4 detalla disposiciones individuales de 90.888; 160.174; 250.665; 473.236; 136.113; 928; y 261.140 acciones a precios medios ponderados entre $91,84 y $96,90 por acción, resultando en importantes reducciones de las participaciones mantenidas indirectamente a través de CW Holding 987 LLC. La presentación revela amplias participaciones indirectas restantes y asignaciones a fideicomisos/entidades, incluyendo 1.200.000 acciones en el Cherry Tree 2024 GRAT y múltiples tenencias en fideicomisos familiares y LLC. El Formulario 4 fue firmado por un apoderado el 04/09/2025.
10b5-1 계획에 따른 CoreWeave 내부자 매도: 이사 잭 D. 코겐은 2025년 9월 2일에 여러 차례 클래스 A 보통주 매각을 보고했으며, 이는 2025년 5월 22일 채택된 Rule 10b5-1 거래 계획에 따라 실행되었습니다. Form 4에는 각각 90,888; 160,174; 250,665; 473,236; 136,113; 928; 및 261,140 주의 처분이 가중평균 주당 $91.84~$96.90 범위의 가격으로 기재되어 있으며, 이는 CW Holding 987 LLC를 통한 간접 보유 지분의 큰 감소를 초래했습니다. 해당 제출서는 남아 있는 광범위한 간접 보유 및 신탁/법인 배분을 공개하며, Cherry Tree 2024 GRAT에 보유된 1,200,000주 및 여러 가족 신탁과 LLC 보유를 포함합니다. Form 4는 2025년 9월 4일 대리인(법정대리인)에 의해 서명되었습니다.
Vente interne CoreWeave via plan 10b5-1 : L'administrateur Jack D. Cogen a déclaré plusieurs ventes d'actions ordinaires de Classe A le 02/09/2025, exécutées dans le cadre d'un plan de négociation Rule 10b5-1 adopté le 22/05/2025. Le formulaire 4 énumère des cessions individuelles de 90 888 ; 160 174 ; 250 665 ; 473 236 ; 136 113 ; 928 ; et 261 140 actions à des prix moyens pondérés allant de $91,84 à $96,90 par action, entraînant d'importantes réductions des actions détenues indirectement via CW Holding 987 LLC. Le dépôt divulgue d'importantes participations indirectes restantes et des allocations à des trusts/entités, y compris 1 200 000 actions détenues dans le Cherry Tree 2024 GRAT et de multiples avoirs en trusts familiaux et LLC. Le formulaire 4 a été signé par un mandataire le 04/09/2025.
CoreWeave Insider-Verkauf über 10b5-1-Plan: Direktor Jack D. Cogen meldete mehrere Verkäufe von Stammaktien Klasse A am 02.09.2025, ausgeführt im Rahmen eines Rule-10b5-1-Handelsplans, der am 22.05.2025 angenommen wurde. Das Formular 4 listet einzelne Veräußerungen von 90.888; 160.174; 250.665; 473.236; 136.113; 928; und 261.140 Aktien zu gewichteten Durchschnittspreisen zwischen $91,84 und $96,90 je Aktie auf, was zu erheblichen Reduzierungen der indirekt über CW Holding 987 LLC gehaltenen Anteile führte. Die Einreichung offenbart umfangreiche verbleibende indirekte Bestände und Zuweisungen an Trusts/Einheiten, darunter 1.200.000 Aktien im Cherry Tree 2024 GRAT sowie mehrere Familien-Trusts und LLC-Beteiligungen. Formular 4 wurde am 04.09.2025 von einem Bevollmächtigten unterschrieben.